CN104419744A - 一种厌氧增菌培养基及其配制方法 - Google Patents
一种厌氧增菌培养基及其配制方法 Download PDFInfo
- Publication number
- CN104419744A CN104419744A CN201310368942.0A CN201310368942A CN104419744A CN 104419744 A CN104419744 A CN 104419744A CN 201310368942 A CN201310368942 A CN 201310368942A CN 104419744 A CN104419744 A CN 104419744A
- Authority
- CN
- China
- Prior art keywords
- anaerobism
- gram
- peptone
- enrichment medium
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 108010080698 Peptones Proteins 0.000 claims abstract description 43
- 239000001888 Peptone Substances 0.000 claims abstract description 42
- 235000019319 peptone Nutrition 0.000 claims abstract description 42
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 claims abstract description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 22
- 239000012153 distilled water Substances 0.000 claims abstract description 22
- 239000008103 glucose Substances 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000011772 phylloquinone Substances 0.000 claims abstract description 20
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 8
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019175 phylloquinone Nutrition 0.000 claims abstract description 5
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims abstract description 5
- 229960001898 phytomenadione Drugs 0.000 claims abstract description 5
- 230000002785 anti-thrombosis Effects 0.000 claims description 34
- 229960004676 antithrombotic agent Drugs 0.000 claims description 34
- 230000001954 sterilising effect Effects 0.000 claims description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 26
- 210000004556 brain Anatomy 0.000 claims description 25
- 238000001802 infusion Methods 0.000 claims description 25
- 229940046307 sodium thioglycolate Drugs 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 21
- 238000002386 leaching Methods 0.000 claims description 21
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 claims description 9
- 229910000020 calcium bicarbonate Inorganic materials 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 9
- 235000010216 calcium carbonate Nutrition 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 108010046845 tryptones Proteins 0.000 claims description 8
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 5
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 244000052616 bacterial pathogen Species 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract description 2
- 238000009629 microbiological culture Methods 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 229940041514 candida albicans extract Drugs 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 229940025294 hemin Drugs 0.000 abstract 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 abstract 1
- 239000012138 yeast extract Substances 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 18
- 239000001301 oxygen Substances 0.000 description 18
- 229910052760 oxygen Inorganic materials 0.000 description 18
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical group C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229960000907 methylthioninium chloride Drugs 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000193159 Hathewaya histolytica Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000193468 Clostridium perfringens Species 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310368942.0A CN104419744B (zh) | 2013-08-22 | 2013-08-22 | 一种厌氧增菌培养基及其配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310368942.0A CN104419744B (zh) | 2013-08-22 | 2013-08-22 | 一种厌氧增菌培养基及其配制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104419744A true CN104419744A (zh) | 2015-03-18 |
CN104419744B CN104419744B (zh) | 2016-10-26 |
Family
ID=52969868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310368942.0A Active CN104419744B (zh) | 2013-08-22 | 2013-08-22 | 一种厌氧增菌培养基及其配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104419744B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107723262A (zh) * | 2017-10-23 | 2018-02-23 | 江苏农牧科技职业学院 | 一种优化的饲用枯草芽孢杆菌发酵培养基及其用途 |
CN109439576A (zh) * | 2018-11-13 | 2019-03-08 | 山东农业大学 | 一种诺维氏梭菌培养基及其制备方法 |
CN110055190A (zh) * | 2019-04-04 | 2019-07-26 | 山东农业大学 | 一种腐败梭菌的培养方法 |
CN111607520A (zh) * | 2020-05-25 | 2020-09-01 | 青海大学 | 刺激Th1细胞增殖活化的肠道微生物的分离培养基及分离培养方法 |
CN111793588A (zh) * | 2020-08-19 | 2020-10-20 | 广东工业大学 | 一种厌氧菌培养基及其制备方法 |
CN112680499A (zh) * | 2021-01-27 | 2021-04-20 | 浙江夸克生物科技有限公司 | 一种厌氧微生物的体外检测试剂盒 |
CN113481120A (zh) * | 2021-06-29 | 2021-10-08 | 广州知易生物科技有限公司 | 培养基及其制备方法、用其培养脆弱拟杆菌的方法 |
CN117487664A (zh) * | 2023-12-29 | 2024-02-02 | 善恩康生物科技(苏州)有限公司 | 双歧杆菌分离培养方法 |
-
2013
- 2013-08-22 CN CN201310368942.0A patent/CN104419744B/zh active Active
Non-Patent Citations (2)
Title |
---|
刘金福: "《临床微生物学检验技术》", 31 August 2007, article "第六节 厌氧培养基", pages: 33-35 * |
陈天寿: "《微生物培养基的制造与应用》", 30 June 1995, article "第三节增菌培养基 十、厌氧菌增菌培养基", pages: 294-295 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107723262A (zh) * | 2017-10-23 | 2018-02-23 | 江苏农牧科技职业学院 | 一种优化的饲用枯草芽孢杆菌发酵培养基及其用途 |
CN109439576A (zh) * | 2018-11-13 | 2019-03-08 | 山东农业大学 | 一种诺维氏梭菌培养基及其制备方法 |
CN110055190A (zh) * | 2019-04-04 | 2019-07-26 | 山东农业大学 | 一种腐败梭菌的培养方法 |
CN111607520A (zh) * | 2020-05-25 | 2020-09-01 | 青海大学 | 刺激Th1细胞增殖活化的肠道微生物的分离培养基及分离培养方法 |
CN111793588A (zh) * | 2020-08-19 | 2020-10-20 | 广东工业大学 | 一种厌氧菌培养基及其制备方法 |
CN111793588B (zh) * | 2020-08-19 | 2023-02-07 | 广东工业大学 | 一种厌氧菌培养基及其制备方法 |
CN112680499A (zh) * | 2021-01-27 | 2021-04-20 | 浙江夸克生物科技有限公司 | 一种厌氧微生物的体外检测试剂盒 |
CN113481120A (zh) * | 2021-06-29 | 2021-10-08 | 广州知易生物科技有限公司 | 培养基及其制备方法、用其培养脆弱拟杆菌的方法 |
CN113481120B (zh) * | 2021-06-29 | 2023-03-21 | 广州知易生物科技有限公司 | 培养基及其制备方法、用其培养脆弱拟杆菌的方法 |
CN117487664A (zh) * | 2023-12-29 | 2024-02-02 | 善恩康生物科技(苏州)有限公司 | 双歧杆菌分离培养方法 |
CN117487664B (zh) * | 2023-12-29 | 2024-03-15 | 善恩康生物科技(苏州)有限公司 | 双歧杆菌分离培养方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104419744B (zh) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104419744A (zh) | 一种厌氧增菌培养基及其配制方法 | |
CN101338283B (zh) | 一种干酪乳杆菌及其在固态发酵中的应用 | |
CN107446852B (zh) | 一株植物乳杆菌及其在发酵饲料方面的应用 | |
CN105567624B (zh) | 一种发酵产乳酸链球菌素的乳酸乳球菌乳亚种用增效剂及其使用方法 | |
CN1943366A (zh) | 富含硒氨基酸的益生菌酸奶的生产方法及其产品 | |
CN108587970B (zh) | 一种产酸克雷伯氏菌及其在促进潞党参生长中的应用 | |
CN106978369A (zh) | 一种高纯度、耐常温贮存屎肠球菌固态发酵培养工艺 | |
CN108102967A (zh) | 一种鸡源凝结芽孢杆菌菌株及其产孢方法 | |
CN108719991B (zh) | 一种利用豆渣和豆腐黄浆水制备含有纳豆菌的红曲的方法 | |
CN104757114A (zh) | 一种虾青素保健酸奶及其制备方法 | |
CN114250164B (zh) | 一种具有固氮、解磷能力的不动杆菌1502ipr-05及其应用 | |
CN113046253A (zh) | 一种提高马克斯克鲁维酵母耐热性的培养方法 | |
CN103497896B (zh) | 一种脱水窖泥功能菌保护剂及其应用 | |
CN104962498B (zh) | 一种乳酸链球菌的发酵培养基及其应用 | |
CN103865832A (zh) | 植物乳杆菌bs10及其在调节猪血脂方面的应用 | |
CN110283855B (zh) | 一种提高嗜热链球菌210202菌株产gaba能力的方法 | |
CN107760724A (zh) | 一种利用多粘类芽孢杆菌制备α‑葡萄糖苷酶抑制剂的方法及该α‑葡萄糖苷酶抑制剂 | |
CN101897385A (zh) | 利用番茄红素提高双岐杆菌发酵水平的方法 | |
CN106754522A (zh) | 一种枯草芽孢杆菌发酵液的制备方法 | |
CN102649969B (zh) | 一种生物锌制剂及其制备方法 | |
CN111513318A (zh) | 一种龙眼酵素的制备方法 | |
CN103211102A (zh) | 饲用生物酸的加工制造方法 | |
CN108378132A (zh) | 一种富硒黑莓汁酸乳发酵的方法 | |
CN115305220B (zh) | 一种具有固氮和促进植物生长能力的假单胞菌及其应用 | |
CN107058193A (zh) | 一种布氏菌病活疫苗s2菌体的高密度发酵方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210918 Address after: 100176 room 603, 6th floor, building 5, yard 15, Ronghua South Road, economic and Technological Development Zone, Daxing District, Beijing Patentee after: BEIJING XINJI JINNUO MEDICAL EQUIPMENT Co.,Ltd. Address before: 252000 East head of Weier Road, Fenghuang Industrial Park, Liaocheng City, Shandong Province Patentee before: SHANDONG XINKE BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220525 Address after: 252019 East head of Wei'Er Road, Fenghuang Industrial Park, Dongchangfu District, Liaocheng City, Shandong Province Patentee after: SHANDONG XINKE BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 100176 room 603, 6th floor, building 5, yard 15, Ronghua South Road, economic and Technological Development Zone, Daxing District, Beijing Patentee before: BEIJING XINJI JINNUO MEDICAL EQUIPMENT Co.,Ltd. |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20240103 Granted publication date: 20161026 |